Clinical Trial Update: A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of MDI-1228_mesylate ophthalmic solution in healthy adults, with the condition of interest b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• MDI-1228_mesylate ophthalmic solution (MDI-1228 mesylate)

Snippet

Sponsor: Shanghai Medinno Pharmaceutical Technology Co., Ltd. | Conditions: Allergic Conjunctivitis | Phase 1 | Status: COMPLETED